T-cell Engagers Market
完整報告名稱與涵蓋範圍
T-cell Engagers Market, Share & Trends Analysis Report, By Application (Therapeutic, Diagnostic/Prognostic, Research), By Technology Type (Bispecific T-cell Engagers (BiTEs), Other Bispecific Antibodies, Next-Gen Engagers), By Cancer Type (Hematologic Cancers, Solid Tumors), By End-User (Hospitals, Specialty Clinics/Outpatient Centers, Research Institutions), By Region, and Segment Forecasts, 2025-2034
報告摘要
The global T-cell Engagers Market is forecasted to progress at a compound annual growth rate of 31.6% throughout the 2025–2034 forecast period.
T-cell Engagers covers a class of engineered antibodies designed to recognize and eliminate harmful cells, such as tumor cells in cancer or autoreactive cells in autoimmune diseases. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is driven by escalating appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global T-cell Engagers Market Snapshot
Chapter 4. Global T-cell Engagers Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on T-cell Engagers Market Industry Trends
4.10. Global T-cell Engagers Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. T-cell Engagers Market Segmentation 1: By Application, Estimates & Trend Analysis
5.1. Market Share by Application, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
5.2.1. Therapeutic
5.2.2. Diagnostic/Prognostic
5.2.3. Research
Chapter 6. T-cell Engagers Market Segmentation 2: By Technology Type, Estimates & Trend Analysis
6.1. Market Share by Technology Type, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology Type:
6.2.1. Bispecific T-cell Engagers (BiTEs)
6.2.2. Other Bispecific Antibodies
6.2.3. Next-Gen Engagers
Chapter 7. T-cell Engagers Market Segmentation 3: By Cancer Type, Estimates & Trend Analysis
7.1. Market Share by Cancer Type, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Cancer Type:
7.2.1. Hematologic Cancers
7.2.2. Solid Tumors
Chapter 8. T-cell Engagers Market Segmentation 4: By End-User, Estimates & Trend Analysis
8.1. Market Share by Cancer Type, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Cancer Type:
8.2.1. Hospitals
8.2.2. Specialty Clinics/Outpatient Centers
8.2.3. Research Institutions
Chapter 9. T-cell Engagers Market Segmentation 5: By Products, Estimates & Trend Analysis
9.1. Market Share by Cancer Type, 2024 & 2034
9.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Cancer Type:
9.2.1. Tecvayli (teclistamab-cqyv)
9.2.2. Elrexfio (elranatamab)
9.2.3. Imdelltra (tarlatamab-dlle)
9.2.4. Kimmtrak (tebentafusp)
9.2.5. Vabysmo (faricimab)
9.2.6. Lunsumio (mosunetuzumab)
9.2.7. Columvi (glofitamab)
9.2.8. Blincyto (blinatumomab)
Chapter 10. T-cell Engagers Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global T-cell Engagers Market, Regional Snapshot 2024 & 2034
10.2. North America
10.2.1. North America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.3. North America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
10.2.4. North America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Cancer Type, 2021-2034
10.2.5. North America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.2.6. North America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.3. Europe
10.3.1. Europe T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.3. Europe T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
10.3.4. Europe T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Cancer Type, 2021-2034
10.3.5. Europe T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.3.6. Europe T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.4.3. Asia Pacific T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
10.4.4. Asia Pacific T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Cancer Type, 2021-2034
10.4.5. Asia Pacific T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.4.6. Asia Pacific T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.5. Latin America
10.5.1. Latin America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.3. Latin America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
10.5.4. Latin America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Cancer Type, 2021-2034
10.5.5. Latin America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.5.6. Latin America T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.6.3. Middle East & Africa T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
10.6.4. Middle East & Africa T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Cancer Type, 2021-2034
10.6.5. Middle East & Africa T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.6.6. Middle East & Africa T-cell Engagers Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Janssen
11.2.1.1. Business Overview
11.2.1.2. Key Application/Service Overview
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Pfizer
11.2.3. Amgen
11.2.4. Bristol-Myers Squibb
11.2.5. Roche
11.2.6. Novartis
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們